Notice of Annual General Meeting 2017

Posted on May 8, 2017

Oslo, 8 May 2017 – The shareholders of PCI Biotech Holding ASA are invited to attend the Annual General Meeting 2017 at Oslo Cancer Cluster Innovation Park. Time: Monday May 29, 10am CEST (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo, Norway. Please find attached […]

Invitation to first quarter 2017 presentation

Posted on May 5, 2017

Oslo, 5 May 2017 – PCI Biotech invites to a presentation of the company’s first quarter 2017 report on Tuesday 16 May 2017 at Oslo Cancer Cluster Innovation Park. Time: Tuesday May 16, 09am – 10am CEST (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo […]

Employee share option scheme

Posted on May 5, 2017

Oslo, 5 May 2017 – In accordance with the authorisation granted by the Annual General Meeting 19 May 2016, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 340,000 share options to key employees. Each share option gives the right to subscribe for or acquire one share per option (after PCI […]